Andrew Paul Mazar - Insider Trading & Ownership

Entity
Individual
Location
1000 Skokie Blvd, Suite 350, Wilmette, IL
Summary
The estimated net worth of Andrew Paul Mazar is at least $94.4K dollars as of August 12, 2024. Andrew Paul Mazar is the Chief Scientific Officer, Director of Monopar Therapeutics and owns shares of Monopar Therapeutics (MNPR) stock worth about $94.4K.
All Insider Reports
All Insider Reports

Ownership of Andrew Paul Mazar

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MNPR Monopar Therapeutics Chief Scientific Officer, Director $94.4K Mar 31, 2022
ACTU ACTUATE THERAPEUTICS, INC. Chief Operating Officer Aug 12, 2024

Insider Transactions Reported by Andrew Paul Mazar:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.